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Effects of three different methods of anesthesia on the release
of brain natriuretic peptid in patients with cardiac risk
undergoing lower extremity surgery
Canan ATALAY1, Celalettin DAĞLI1 , Ednan BAYRAM2, Hacı Ahmet ALICI1,
Ali Fuat ERDEM1, Mevlüt Sait KELEŞ3, Şahin YÜKSEK1
Aim: To investigate if intra and postoperative thoracal epidural analgesia could decrease plasma concentrations of brain
natriuretic peptide (BNP) in patients who were at risk for, or had, coronary artery disease (CAD) and undergoing lower
extremity operations.
Materials and methods: Sixty patients with risk of CAD scheduled to undergo lower extremity surgery were divided into
3 groups. Group G was administered general anesthesia followed by intravenous patient-controlled analgesia (I.V PCA)
(n = 20). Group L was administered lumbar epidural anesthesia followed by lumbar epidural analgesia (n = 20). Group
T was administered general anesthesia combined with intra and postoperative thoracal epidural analgesia as well as I.V
PCA (n = 20). Visual analog scale pain scores, hemodynamics, plasma catecholamines, cardiac troponin I (cTnI), atrial
natriuretic peptide (ANP), and BNP were measured preoperatively and measurements were extended to 90 min after
skin incision, towards the end of surgery, and in the morning of day 1, 2, and 3 postoperation. The data were statistically
compared using multiple comparison tests.
Results: Baseline ANP and BNP concentrations were similar in all groups (G: 25.8 ± 4.51 and 25.9 ± 8.52 pg/mL; L: 23.9
± 3.67 and 20.8 ± 9.8 pg/mL; T: 24.7 ± 4.27 and 23.0 ± 5.98 pg/mL, respectively). The postoperative plasma BNP
concentrations of group T were lower than those of groups L and G. and similarly group L was lower compared to group
G in terms of postoperative plasma BNP concentrations (P < 0.05). Peak plasma concentrations of BNP were 162.4 ± 29.4,
110.6 ± 12.2, and 69.0 ± 6.9 for groups G, L, and T, respectively (P < 0.05). However, there was no group difference in
peak plasma ANP concentrations. Baseline epinephrine and norepinephrine concentrations were also similar across the
groups. Peak plasma epinephrine concentrations of group T were lower than those of groups G and L (P < 0.05). Plasma
cTnI concentrations were within normal limits (<0.1 μg/L) in all the 3 groups and no difference in plasma cTnI was
observed among the groups throughout the study (P < 0.05). The plasma cTnI concentration did not correlate with either
the ANP or BNP concentration in each group.
Conclusion: Lower plasma BNP level for patients in group T comparing with patients in other groups and in group L
compared to group G may suggest that opioids and local anesthetics could contribute to the positive effects of thoracal
epidural analgesia and lumbar epidural anesthesia plus analgesia through inhibition of BNP release.
Key words: BNP, thoracal epidural analgesia, lumbar epidural anesthesia

Alt ekstremite cerrahisi uygulanacak kardiyak riskli hastalarda üç farklı
anestezi metodunun Brain natriüretik peptid salınımına etkisi
Amaç: İntra ve postoperatif torakal epidural analjezinin (TEA) ve lumbar epidural anestezi (LEA) ve analjezinin koroner
arter hastalığı olan veya riski taşıyan ve alt ekstremite cerrahisi uygulanan hastalarda brain natriüretik peptid (BNP)
plazma konsantrasyonuna etkisini incelemeyi amaçladık.
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Yöntem ve gereç: Koroner arter hastalığı olan veya riski taşıya alt ekstremite cerrahisi uygulanacak 60 hasta rastgele 3
gruba ayrıldı. Grup G: Genel anesteziyi takiben intravenöz hasta kontrollü analjezi (I.V PCA), Grup L: Lumbar epidural
anesteziyi takiben lumbar epidural analjezi, Grup T: Genel anestezi ve torakal epidural analjeziyi takiben IV PCA
uygulandı. VAS ağrı skoru, plazma katekolaminleri, kardiyak troponin I, atriyal natriüretik peptid ve BNP değerleri
preoperatif, cilt insizyonundan 90 dakika sonra, cerrahinin sonunda postoperative 1, 2, 3. günün sabahı ölçüldü. Verilerin
analizi için ANOVA ve Duncan testi uygulandı.
Bulgular: Bütün gruplarda bazal ANP ve BNP konsantrasyonları benzerdi (G: 25,8 ± 4,51 ve 25,9 ± 8,52 pg/mL; L: 23,9
± 3,67 ve 20,8 ± 9,8 pg/mL; T: 24,7 ± 4,27 ve 23,0 ± 5,98 pg/mL sırasıyla). T grubu postoperative BNP konsantrasyonu
diğer iki gruptan, L grubu ise Grup G’den düşüktü (P < 0.05). BNP pik plazma konsantrasyonu G grubunda 162,4 ± 29,4
pg/mL; L grubunda 110,6 ± 12,2 pg/mL; ve T grubunda 69,0 ± 6,9 pg/mL idi. ANP pik plazma konsantrasyonunda
önemli farklılık yoktu (P < 0,05). Bazal epinefrin ve norepinefrin konsantrasyonu tüm gruplarda benzerdi. Epinefrin pik
plazma konsantrasyonu Grup T de diğer iki gruba gore düşüktü. (P < 0,05). Plazma cTnI konsantrasyonu her üç gruptada
normal sınırlar içindeydi (<0,1 μgmL-1) ve çalışma süresince gruplar arasında farklılık gözlenmedi. Plazma cTnI
konsantrasyonu ANP ve BNP konsantrasyonları ile önemli bir korelasyon göstermedi (P < 0,05).
Sonuç: BNP düzeyi intra ve postoperatif torakal epidural analjezi uygulanan grupta diğer iki gruba göre, Lumbar epidural
anestezi ve analjezi uygulanan grupta da genel anestezi grubuna göre azaldı. Biz opioid ve lokal anesteziklerin pozitif
katkısı olduğunu düşünüyor ve kardiyak riskli hastalarda torakal epidural analjezi kullanılmasını öneriyoruz.
Anahtar sözcükler: BNP, torakal epidural analjezi, lumbar epidural anestezi.

Introduction
Coronary artery disease (CAD) constitutes the
majority of cardiac diseases. Perioperative myocardial
ischemia is known to be the single most important
predictor of the cardiac outcome, such as (unstable
angina, myocardial infarct, and sudden death) in
patients with CAD or those at risk for CAD (1,2).
Surgical and anesthesia techniques for major
operations are continuously being improved to
minimize these fatal outcomes, reduce the cost, and
help patients return to their normal activities as soon
as possible. The role of postoperative epidural
analgesia in reducing perioperative risk is
controversial (3). Thoracic epidural analgesia (TEA)
however provides various benefits including
myocardial ischemia reduction (3-5). In addition to
pain relief, TEA may decrease cardiac morbidity
through correcting the myocardial oxygen balance
and modulating the sympathetic response (3,4). Both
lumbar epidural anesthesia (LEA) and analgesia
reduce pulmonary and cardiac complications, and
improve myocardial oxygenation and tissue
reperfusion (6).
The majority of patients with perioperative
ischemia remain asymptomatic, and serum markers
of myocardial ischemia, such as CK-MB and cardiac
troponins, usually do not increase (4,7). The ischemic
heart disease without myocyte necrosis is
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characterized by activation of the natriuretic peptide
system (7,8). Natriuretic peptides are synthesized by
the heart and regulate arterial blood pressure,
electrolyte balance, and fluid volume (9,10). The
diagnostic and prognostic value of these cardiac
hormones in non-surgical patients with or without
symptomatic cardiac disease has been confirmed by
several studies (11,12). However, studies on the role
of epidurals on the release of cardiac natriuretic
peptides in patients undergoing major surgery and
anesthesia are limited (4,8).
We conducted this study to determine if the
supplementation of general anesthesia with intra and
postoperative thoracal epidural analgesia could
decrease plasma concentrations of brain natriuretic
peptide (BNP) in patients with CAD or those at risk
for CAD scheduled to undergo major lower extremity
surgery.
Materials and method
The study was approved by Atatürk University
Ethics Committee, and written informed consent was
obtained from each patient. Additionally, all patients
were given a comprehensive explanation of the
anesthetic techniques, informed about the benefits of
optimal pain management, and instructed to notify
the attending physician or nurse in case of any pain.
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In patient selection, presence and/or risk for CAD
as well as planned lower extremity surgery were
considered. Presence of CAD was ascertained by
history of myocardial infarction and diagnosis of
typical angina or atypical angina with a positive stress
test. Risk for CAD was based on age (65 years old),
blood pressure, smoking habit, blood cholesterol
(>240 mg/dL), and diabetes. Moreover patients were
excluded from the study if they met the following
conditions: 1) severe impairment of left ventricular
function (ejection fraction <35%-40%), 2) severe
symptomatic mitral or aortic valve disease, 3)
decompensated congestive heart failure, 4)
symptomatic arrhythmias, 5) liver dysfunction
(alanine
aminotransferase
and
aspartate
aminotransferase > 40 U/L), 6) renal failure requiring
hemodialysis, 7) known allergies to the drugs used in
the present study, 8) contraindications to dural
perforation (chronic back pain or previous lumbar
spinal surgery in the area of puncture, localized
infection, and use of an antiplatelet drug within 3 days
before the surgery), and 9) unusual blood coagulation
tests (activated partial thromboplastin time > 40 s,
international normalized ratio > 1.25, fibrinogen
concentration < 1 g/L, platelet count < 150 × 109/L)
(4).

of lidocaine 1.5% was injected to exclude the
intrathecal placement of the epidural catheter.
Epidural blockade was achieved by an initial 10-15
mL bolus of 5 mg/mL of bupivacaine and 5 μg/mL of
fentanyl, depending on patient size and catheter
placement. Somatosensory blockade was checked by
evaluating the cold sensitivity of the skin with ice and
the pinprick test. Surgery was allowed if the level of
block was ensured to be below Th10. Every 1-2 h, 10
mL of the same solution was administered. For
postoperative analgesia 10-12 mL of 1.25 mg/mL
bupivacaine + 2 μg/mL fentanyl mixture was delivered
from the epidural catheter when VAS score was
greater than 3.
For group T, an epidural catheter was inserted
between a replace T2 and T5 before the induction of
general anesthesia. A test dose of 3 mL of lidocaine
1.5% was injected to exclude the intrathecal
placement of the epidural catheter. Epidural blockade
was achieved by an initial bolus of 10-12 mL of 1.25
mg/mL bupivacaine and 2 μg/mL fentanyl depending
on patient size and catheter placement. The extent of
the epidural blockade was recorded. The same dose
of the same solution was administered at every hour
throughout the operation. For TEA, the same dose of
the same solution was administered every 3 h during
the postoperative period.

A total of 60 patients who met the selection criteria
were randomly allocated to 1 of the 3 groups. Group
G (n = 20) received general anesthesia followed by IV
patient-controlled analgesia (IV PCA), group L (n =
20) received lumbar epidural anesthesia followed by
lumbar epidural analgesia, and group T (n = 20)
received general anesthesia combined with TEA and
IV PCA. To avoid the risk for epidural hematoma,
anesthesia personnel and nurses were also informed
about the study groups and no patient was subjected
to a sham epidural insertion. A routine clinical
examination including a detailed medical history,
physical examination, laboratory tests, chest
radiography, and 12-lead electrocardiogram (ECG)
was performed for all patients before the operation.
Preoperative cardiac medications were used until the
day of surgery. All patients received intramuscular
midazolam (3.5 mg) 1 h before surgery.

Anesthesia of the patients in groups G and T was
induced using weight-adjusted doses of thiopental (3
to 5 mg/kg), fentanyl (2 μg/kg), and rocuronium
bromide (0.6 mg/kg). After intubation of the trachea,
the lungs were ventilated with 40% O2 + 60% N2O.
Ventilation was set to a tidal volume of 10 mL/kg. The
ventilation rate was adjusted to keep the end tidal CO2
between 35% and 45%. Anesthesia was maintained
with sevoflurane and additional bolus injections of
rocuronium bromide. Additional bolus injections of
fentanyl (0.1 mg, i.v.) were used to sustain
intraoperative analgesia in both groups by the order of
the attending anesthesiologist. Doses of anesthetics
were titrated to provide optimal anesthesia as
reflected by lacks of movement, lacrimation, and
sweating and surgical state, while maintaining
hemodynamic stability.

For group L, an epidural catheter was placed
between L4 and L5 through the median approach
using the hanging drop technique. A test dose of 3 mL

IV-PCA was started in both groups G and T for
postoperative analgesia. After i.v. bolus of injection of
3 mg morphine initially, patients were connected to a
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PCA pump (Abbott Pain Management Provider,
North Chicago, IL, USA) delivering a continuous
infusion of 0.3 mg/h and 1 mg i.v. bolus of morphine
on demand with a 15 min lock-out interval and 8 mg
of 4-h limit. Fluid balance was monitored. It would be
invalid to replace the evaporative loss, which is the
loss of free water, with the lactated Ringer's solution.
Perioperative monitoring included pulse oximetry,
continuous monitoring of leads II and V5 of the ECG
with automated ST segment analysis, and continuous
invasive measurement of mean arterial pressure
(MAP) and central venous pressure (CVP).
Patients were extubated in the intensive care unit
(ICU). From day 1 to 3 postoperation days (PODs),
all patients were evaluated at least twice a day to adjust
the dose of analgesics, to avoid insufficient analgesia,
by a physician in the acute pain department. The
analgesic demand in all groups was supplied to obtain
a VAS pain score < 3 during rest and a dynamic pain
score (i.e., scoring the pain during movement,
coughing, or taking deep breaths) of < 5 (0 = no pain;
10 = worst pain)). Analgesic use in both groups was
further reviewed during the daily visits by the
physicians in the acute pain department in order to
optimize the analgesia while minimizing side effects,
such as sedation, respiratory depression, nausea,
pruritus, and hemodynamic instability. Venous blood
specimens were obtained preoperatively, 90 min after
skin incision, towards the end of surgery, and in the
morning of the PODs 1, 2, and 3 ; and stored at -40 °C
until analysis. The following variables were
determined using commercially available laboratory
kits: BNP (Triage BNP test, Biosite Inc., France), a
result >80 pg mL-1 was considered an indication of
neurohormonal activation in patients with acute
coronary syndromes [10]; atrial natriuretic peptides
(ANP) (ANP Eliza kit, Biosupply, UK), with a
reference value in the range of 10-70 pg/mL in healthy
men under 65 years of age [10]; and cardiac troponin
I (cTnI) (Troponin I Enzyme Immunoassay; Biosite,
Germany) with levels up to 0.1 μg/L as normal. The
plasma concentrations of epinephrine and
norepinephrine were measured by reverse-phase
high-performance liquid chromatography (HPLC).
We considered any decrease in BNP with thoracal
epidural analgesia as a primary outcome. To achieve
30% reduction in BNP, power analysis at an alpha
408

error of 0.05 with a power (beta error) of 0.80 revealed
a sample size of 19 patients in each group. The data
were analyzed by ANOVA and Duncan test was used
for group difference (SPSS 11.5 for Windows,
Chicago, IL, USA). All data were expressed as either
mean ± SD or quartiles and statistical significance was
declared at P < 0.05.
Results
A total of 60 patients were included in the study.
Table 1 shows similarity of the patients, with respect
to cardiac risk factors preoperative medication, and
surgery type across the groups. There were no
differences in the anesthesia, surgery, and ICU
durations, blood loss, urine output, fluid and blood
amounts administered perioperatively, and hospital
stay among the study groups (Table 2). Hemodynamic
measurements did not differ among the patients in
none of the groups, except the heart rate, which was
the lowest among patients in group T (Table 3). The
postoperative dynamic VAS scores were similar across
the study groups. The baseline ANP and BNP
concentrations were also similar among the groups (
25.8 ± 4.51 and 25.9 ± 8.52 pg/mL for group G, 23.9 ±
3.67 and 20.8 ± 9.8 pg/mL for group L, 24.7 ± 4.27 and
23.0 ± 5.98 pg/mL for group T (Figures 1and 2). The
variables changed over time; increased toward the end
of surgery and remained high, regardless of the study
groups.
The
postoperative
BNP
plasma
concentrations for group T was the lowest, followed
by groups L and G (P < 0.05; Figure 1); and group L
was lower compared to the G group. The BNP peak
plasma concentrations were 162.4 ± 29.4, 110.6 ± 12.2
and 69.0 ± 6.9 pg/mL for patients in groups G, L, and
T, respectively (P < 0.05; Figure1). There was no
group difference in the peak plasma ANP
concentrations. It was 64.0 ± 4.48, 60.4 ± 2.4, and 58.1
± 3.11 pg/mL patients in group G, L, and T,
respectively (P < 0.05; Figure 2). The baseline
epinephrine and norepinephrine concentrations were
similar in all groups (Figures 3 and 4). Plasma
concentrations of epinephrine at the end of surgery
and 90 min after surgery were lower among patients
in group T than those among the patients in groups G
and L (P < 0.05; Figure 3). The plasma cTnI
concentrations were within normal limits (<0.1μg/L)
in all patients throughout the study period without a
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Table1. Patient data, medication, and type of surgery.

Age
Sex (M/F)
Weight (kg)
Typical angina

Group L
(n = 20)

Group G
(n = 20)

Group T
(n = 20)

67 ± 3

66 ± 2

67 ± 2

9/11

8/12

9/11

75 ± 11

74 ± 13

72 ± 9

3

2

4

Diabetes

5

6

7

Smoker

11

11

13

Hypercholesterolemia

9

8

6

Hypertension

10

11

12

ACEI

6

8

13

Diuretics

5

6

4

β- Blockers

11

9

6

Total hip arthroplasty

11

10

12

Hip arthroplasty

9

10

8

Preoperative medications

Type of surgery

Values are expressed as mean ± SD or number of patients (n). ACEI: angiotensin-converting enzyme inhibitor. There were no group
differences (P < 0.05).

Table 2. Perioperative data
Group L

Group G

Group T

(n = 20)

(n = 20)

(n = 2 0)

Duration of surgery (min)

180 ± 67

175 ± 50

160 ± 63

Duration of anesthesia (min)

224 ± 65

238 ± 55

230 ± 50

Intraoperative blood loss (mL)

398(250-875)

410(275-978)

400(280-985)

intraoperative urine output (mL)

320(210-570)

325(240-630)

315(250-625)

intraoperative volume infusion (mL)

3500(3000-4000)

3600(3100-4300)

3550( 3000-4250)

POD1

3200(2200-4250)

3000(2100-4000)

3250(2250- 4275)

POD2

3100(2100-4200)

2950(2100-4150)

3150(2200-4200)

POD3

2500(2000-3500)

2550(1900-3250)

2550(1800-2950)

ICU length of stay (days)

2 (1-3)

2 (1-3)

2(1-3)

In-hospital mortality (%)

0

0

0

10 (9-11)

12 (9-16)

9 (8-10)

Postoperative hospital stay (days)

Values are expressed as mean ± SD, number of patients (n) or median. POD = postoperative day, ICU: intensive care unit. There were
no group differences (P < 0.05).
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Table3. Hemodynamic variables.

Time and Group
Baseline
G
L
T
90 min
G
L
T
End of surgery
G
L
T
POD 1
G
L
T
POD 2
G
L
T
POD 3
G
L
T

HR

MAP (mmHg)

CVP (mmHg)

79.4 ± 7
78.7 ± 6
77.5 ± 5

84.9 ± 12
85.3 ± 9
85.2 ± 9

10 ± 3
11 ± 2
11 ± 2

80.1 ± 5
80.5 ± 8
68.2 ± 4*†

83.2 ± 8
84.1 ± 12
80.7 ± 5

12 ± 4
11 ± 2
10 ± 1

82.4 ± 8
84.5 ± 7
65.2 ± 7*†

83.7 ± 6
85.2 ± 9
82.2 ± 7

13 ± 3
13 ± 4
12 ± 3

80.4 ± 7
79.6 ± 10
78.2 ± 4

84.5 ± 14
84.1 ± 11
83.3 ± 9

14 ± 4
13 ± 3
12 ± 3

77.7 ± 6
75.2 ± 8
76.5 ± 5

85.4 ± 10
83.2 ± 10
82.4 ± 6

12 ± 3
13 ± 4
12 ± 5

75.3 ± 10
73.4 ± 9
72.4 ± 3

84.4 ± 9
83.1 ± 13
82.5 ± 10

11 ± 4
12 ± 3
12 ± 4

Values are expressed as mean ± SD. They are reported at baseline (induction of anesthesia), 90 min after skin incision, end of surgery
and PODs 1, 2, and 3. HR = heart rate, MAP = mean arterial blood pressure, CVP = central venous pressure in both groups. * P < 0.05
compared to other groups. † P < 0.05 ; significantly different from baseline.

group difference (Table 4). The plasma cTnI
concentration was correlated with neither the ANP
nor BNP concentration in each group.
Discussion
The perioperative stress is associated with
hypercoagulability
and
the
release
of
proinflammatory cytokines into the circulation
caused by excessive activity of the neuroendocrine
systems, particularly due to insufficient pain control
in the postoperative period (3). Vasospasm caused by
this stress response impairs the coronary blood flow
and consequently increased contractility of the
410

myocardium disturbs the balance between the supply
and the need for oxygen that may lead to outcomes
ranging from myocardial ischemia to severe cardiac
injury (2,4,8).
BNP is recognized as a marker to determine the
acute risk of patients with cardiovascular condition
ranging from asymptomatic myocardial ischemia
without ST segment elevation to acute transmural
myocardial infarction (11). We postulated that TEA
in addition to general anesthesia would suppresses the
neurohormonal response and epidural administration
of local anesthetics and opioids attenuated BNP
release in patients undergoing lower extremity
surgery. In this study, intra- and postoperative TEA
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Table 4. Perioperative changes in cTnI (μgL ).

180
*

Group G
Group L

140

*

GroupT

-1
BNP (pgmL )

120

*§
*§

100
80

*

*†
*†

60

*

*§

*§

*†

40

*†

20
0
Baseline

90min

EOS

POD1

POD2

POD3

Figure 1. Perioperative changes in brain natriuretic peptide
(BNP). Values are expressed as mean ± SD baseline
(induction of anesthesia), 90 min (90 min after skin
incision), EOS (end of surgery), PODs (postoperative
days) * P < 0.05: significantly different from baseline. †
P < 0.05 compared to other groups. § P < 0.05 different
from G. Group G= General anesthesia + IV PCA,
group L = Lumbar epidural anesthesia + analgesia,
group T = General anesthesia +Thoracal epidural
analgesia + IV PCA.

120

Gorup G
Group T

ANP (pgmL -1 )

Group T
(n = 20)

Group L
(n = 20)

Group G
(n = 20)

0.03 ± 0.01
0.03 ± 0.01
0.03 ± 0.01
0.04 ± 0.01
0.03 ± 0.01
0.02 ± 0.01

0.02 ± 0.01
0.03 ± 0.01
0.04 ± 0.01
0.04 ± 0.01
0.03 ± 0.01
0.03 ± 0.01

0.03 ± 0.01
0.03 ± 0.02
0.04 ± 0.01
0.04 ± 0.01
0.03 ± 0.02
0.03 ± 0.01

Values are expressed as mean ±SD. Baseline (induction of
anesthesia), 90 min (90 min after skin incision), EOS (end of
surgery), PODs (postoperative days) Plasma cTnI were not
diffrrent among the groups throughout the study period (P <
0.05), no significant difference.
1200
1000
*

800

GroupT

*

*

600
*†

400

*†
*
*

Baseline

60
*
40

*

*

*

20
0
90min

Group L

0

80

Baseline

Group G

*

200

Group L

100

Baseline
90min
EOS
POD1
POD2
POD3

Epinephrine (pgmL -1)

160

EOS

POD1

POD2

90min

EOS

POD1

POD2

POD3

Figure 3. Perioperative changes in epinephrine. Baseline
(induction of anesthesia), 90 min (90 min after skin
incision), EOS (end of surgery), PODs (postoperative
days) * P < 0.05: significantly different from baseline.
+ P < 0.05: compared to other groups. Group G =
General anesthesia + IV PCA, group L = Lumbar
epidural anesthesia + analgesia, group T= General
anesthesia +Thoracal epidural analgesia+ IV PCA.

POD3

Figure 2. Perioperative changes in atrial natriuretic peptide
(ANP). Values are expressed as mean ± SD. Baseline
(induction of anesthesia), 90 min (90 min after skin
incision), EOS (end of surgery), PODs (postoperative
days) * P < 0.05: significantly different from baseline.
Group G = General anesthesia + IV PCA, group L =
Lumbar epidural anesthesia + analgesia, group T =
General anesthesia + Thoracal epidural analgesia + IV
PCA.

used for patients with cardiac risk decrease the release
of BNP, and also BNP release was lower in the LEA
and analgesia group compared to the general
anesthesia and IV PCA group.
The ANP and BNP concentrations are used as
markers of myocardial function (11). Increased
plasma BNP level reflects the extent and severity of
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Figure 4. Perioperative changes in norepinephrine. Values are
expressed as mean ± SD. Baseline (induction of
anesthesia), 90 min (90 min after skin incision), EOS
(end of surgery), PODs (postoperative days) * P < 0.05:
significantly different from baseline. Group G =
General anesthesia + IV PCA, group L= Lumbar
epidural anesthesia + analgesia, T = General anesthesia
+ Thoracal epidural analgesia + IV PCA.

an ischemic insult, as well as the degree of left
ventricular dysfunction resulting from myocardial
ischemia even when myocyte necrosis has not
occurred (8,10). When sympathoadrenal and
neurohormonal activation increase in response to
ischemic myocardial injury, ANP and BNP act as
counter regulatory hormones (4,11). In patients with
cardiovascular circumstance, such as unstable angina,
acute coronary syndromes, heart failure, or larger
concentrations of BNP, are associated with increased
cardiovascular and overall mortality (11-14).
The combination of epidural analgesia with
general anesthesia is a method employed frequently
for major operations. This combination suppresses
the hormonal and autonomous response to surgery
by inhibiting afferent stimuli (4), suggesting that the
use of continuous TEA for perioperative pain
management in patients with CAD modulates the
neurohormonal pathways to produce anti-ischemic
actions and decreases the severity of myocardial
ischemia (8,10,12,15). In a study involving 40 patients
with unstable angina, lausson et al. performed a
blockade of upper 5 thoracal segments by continuous
bupivacaine infusion through TEA (16). They
concluded that TEA reduced the heart rate without
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affecting the MAP and coronary perfusion pressure,
and therefore exerted a positive effect on the oxygen
balance of the myocardium. A meta-analysis study by
Beattie et al. (17) demonstrated that pain
management with TEA for 24 h after surgery reduced
the postoperative myocardial infarction (PMI) rate by
40% and reported that TEA was superior to lumbar
epidural analgesia in reducing PMI. Stunner et al. (4)
also performed continuous intra- and postoperative
TEA in patients undergoing major abdominal surgery
and reported that TEA attenuated BNP release.
In our study, intra- and postoperative BNP levels
in patients who had received TEA were significantly
lower compared to the other 2 groups.
Lumbar epidural anesthesia and analgesia are
associated with a lower incidence of reoperation,
which may be advantageous for this surgical
population (6,18). In several studies comparing
epidural analgesia with IV PCA, it has been
demonstrated that epidural analgesia is superior in
terms of pain relief in orthopedic, general surgical
patients when compared with PCA. Additional
advantages of epidural analgesia in comparison with
i.v opioids for postoperative pain control include
reduction of pulmonary and cardiac complications
and improvement in myocardial oxygenation and
tissue reperfusion (6,19). Cardiac morbidity was
shown to be lower among patients undergoing major
vascular surgery after the administration of general
combined anesthesia and postoperative epidural
analgesia compared to the administration of general
anesthesia alone and postoperative systemic opioid
analgesia (20). A meta-analysis revealed a significant
reduction in venous thromboembolism in patients
undergoing surgery for hip fracture under regional
anesthesia compared with general anesthesia, but
resulted in only a marginally better effect on early
mortality (21). In our study, intra- and
postoperatively, the BNP levels of the group L were
significantly lower compared to group G.
Christopherson et al. (18) compared epidural and
general anesthesia in terms of myocardial ischemia,
MAP, and HR in high-risk patients scheduled for
lower extremity vascular surgery. Their results
showed significantly lower MAP and HR values in the
LEA group, and did not show a difference in
myocardial ischemia between groups. In our study
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MAP and HR values did not show remarkable
difference compared to general anesthesia due to
administration of below Th10 levels and absence of
sympathetic blockade in group L.
In non-surgical patients, increased plasma BNP
values may be used as diagnostic and prognostic
markers to assess asymptomatic myocardial ischemia
without ST segment elevation (4,8,11). However, it is
unclear whether an increase of ANP and BNP after
surgery indicates myocardial ischemia in patients
without symptoms. In a meta-analysis it was reported
that performance of BNP and NT-pro-BNP were at
least equivalent to the best of the traditional
preoperative diagnostic tests of cardiac morbidity for
vascular surgical patients. Rodseth et al. (8), however,
emphasized that the performance of BNP and NTpro-BNP as pre-operative diagnostic tests may be
better than what it was presented in that metaanalysis. ANP and BNP are considered to have
different but complementary functions in the
regulation of cardiovascular homeostasis (10). BNP is
more sensitive for left ventricular damage than ANP
(10). The mean concentration of ANP in healthy
volunteers was 26.8 ± 9.7 pg/mL., whereas the mean
control value for BNP was 15.9 ± 9.6 pg/mL. De
Lemos et al (11) studied the prognostic value of BNP
in the acute coronary syndrome in 2525 patients with
ischemic symptoms. The authors determined that a
BNP level above 80 pg/mL was associated with
mortality and new or recurrent myocardial infarction
more than those with a level of ≤ 80 pg/mL.. They
thought that cut off point was neurohumoral because
at pre, peri, and postoperative periods there was no
cardiac complication and death. BNP may also be
considered an indicator of reduced cardiac
performance rather than structural myocardial
damage, because all natriuretic peptides have different
release mechanisms. Since some endogenous
vasoactive
factors,
neurotransmitters,
proinflammatory cytokines, and hormones may

directly stimulate ANP and BNP releases, natriuretic
peptides exhibit variable behaviors (10,12). ANP may
regulate blood pressure and water-electrolyte balance,
whereas BNP may act as a ventricular local regulator
for protecting the heart from damage and fibrosis (8).
Plasma concentrations of natriuretic peptides may
also increase after transient volume load due to
perioperative fluid administration (9). Berendes et al.
(10) observed that ANP and BNP had variable
secretion patterns in cardiac surgery patients. We
performed volume replacement according to CVP
monitoring. As the ANP values did not exceed the
normal limits, no difference was observed among
groups. In our study higher plasma BNP values
among patients in group G could be related to a
possible increase in the left ventricular wall stress
secondary to transient myocardial ischemia.
Cardiac specific troponins (cTnI) are common
biochemical indicators used for the diagnosis of
myocardial infarction and unstable angina pectoris
and assessment of the prognosis (22). Although a
slight increase in the troponins does not suffice to
indicate extensive myocardial damage, high levels
may be accepted as an indicator of myocardial
damage. In the present study, there was neither ST
change nor difference in plasma cTnI concentration
among groups. Concentrations of cTnI was
independent from ANP and BNP releases.
In conclusion, BNP release was lower upon intra
and postoperative TEA group compared to 2 other
groups and in LEA + analgesia group compared to the
general anesthesia group among patients with or at
risk for coronary artery disease undergoing lower
extremity operations. We believe that opioids and
local anesthetics also contributed to the positive
effects of TEA and lumbar epidural anesthesia plus
analgesia. For high-risk cardiac patients, epidural
anesthesia followed by epidural postoperative
analgesia should be preferred.
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